Keros Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -327.2% | – | – | – | – | – | – | |
| – | +186.3% | -36.5% | +36.0% | +78.3% | +20.9% | +50.8% | +22.8% | |
| – | -27.2% | +6,844.1% | +186.1% | +59.4% | +54.0% | +21.2% | -17.7% | |
| – | +937.8% | +107.2% | +99.0% | +58.9% | – | – | – | |
| – | -184.6% | – | -806.4% | – | -118.5% | – | – | |
| – | +24.9% | +8.5% | +248.3% | +21.2% | +98.5% | -21.6% | -19.7% | |
| – | +24.9% | +8.5% | +248.3% | +21.2% | +98.5% | -21.6% | -19.7% | |
| – | -99.9% | +2,135,707.1% | -90.5% | +321.4% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -99.9% | +2,114,500.0% | -90.4% | +321.4% | +48.7% | +118.9% | -196.6% | |
| – | -188.8% | – | -113.4% | – | +6.1% | +340.6% | -219.0% | |
| – | -338.4% | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.